Teva Pharmaceutical Industries Limited is believed to be in preliminary discussions to buy Handok Pharmaceuticals Co., Ltd., according to reports in JoongAng Dail. Young-Jin Kim, Chief Executive Officer and Chairman of Handok, holds 46.8% of Hando and IMM Private Equity owns 30% of Handok.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.01 USD | -0.64% | -1.22% | +62.93% |
Jun. 14 | Global markets live: Tesco, Adobe, Tyson Foods, GameStop, Teva... | |
Jun. 14 | Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.93% | 19.27B | |
+52.93% | 803B | |
+40.98% | 631B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 243B | |
+2.17% | 228B | |
+10.66% | 217B | |
+6.24% | 164B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Reportedly In Talks To Acquire Handok Pharmaceuticals